1 terminated, 1 withdrawn. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Terminated 1, Withdrawn 1 |
Follow Stage IIIC Melanoma: new trials by email Literature Review of Stage IIIC Melanoma trials Research Report on Stage IIIC Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FDG-PET in Advanced Melanoma [18F]fluorodeoxyglucose, Molecular assays on biopsied tissue, positron emission tomography - Recurrent Melanoma, Stage IIIA Melanoma | Not applicable | Terminated | Vanderbilt-Ingram Cancer Center | 3 | 2012-05-01 | 2017-04-13 |
| Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma isolated limb perfusion, melphalan, quality-of-life assessment - Basal Cell Carcinoma of the Skin, Eccrine Carcinoma of the Skin | Not applicable | Withdrawn | Albert Einstein College of Medicine | 2012-04-01 | 2015-07-23 |
Melanoma (2) · Carcinoma, Basal Cell (1) · Sarcoma (1) · Skin Neoplasms (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Nevi and Melanomas (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Carcinoma (1) · Neoplasms, Basal Cell (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Glandular and Epithelial (1) · Skin Neoplasms (1)
Gene Expression (1) · Immunohistochemistry (1) · Melphalan (1) · Positron-Emission Tomography (1) · Tissue Array Analysis (1) · Tomography, Emission-Computed (1) · Tomography, X-Ray Computed (1)
Albert Einstein College of Medicine (1) · Vanderbilt-Ingram Cancer Center (1)
United States (2)
Katia Papalezova (1) · Tom Yankeelov, PhD (1)
P30CA013330 (1), P30CA068485 (1)